These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19275730)

  • 1. Role of the HIV-1 positive elongation factor P-TEFb and inhibitors thereof.
    Wang Y; Liu XY; De Clercq E
    Mini Rev Med Chem; 2009 Mar; 9(3):379-85. PubMed ID: 19275730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex.
    Biglione S; Byers SA; Price JP; Nguyen VT; Bensaude O; Price DH; Maury W
    Retrovirology; 2007 Jul; 4():47. PubMed ID: 17625008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of flavopiridol analogues that selectively inhibit positive transcription elongation factor (P-TEFb) and block HIV-1 replication.
    Ali A; Ghosh A; Nathans RS; Sharova N; O'Brien S; Cao H; Stevenson M; Rana TM
    Chembiochem; 2009 Aug; 10(12):2072-80. PubMed ID: 19603446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirubin-3'-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication.
    Heredia A; Davis C; Bamba D; Le N; Gwarzo MY; Sadowska M; Gallo RC; Redfield RR
    AIDS; 2005 Dec; 19(18):2087-95. PubMed ID: 16284457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human immunodeficiency virus type 1 Tat-like arginine-rich RNA-binding domain is essential for HEXIM1 to inhibit RNA polymerase II transcription through 7SK snRNA-mediated inactivation of P-TEFb.
    Yik JH; Chen R; Pezda AC; Samford CS; Zhou Q
    Mol Cell Biol; 2004 Jun; 24(12):5094-105. PubMed ID: 15169877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).
    Chiu YL; Cao H; Jacque JM; Stevenson M; Rana TM
    J Virol; 2004 Mar; 78(5):2517-29. PubMed ID: 14963154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.
    Dow EC; Liu H; Rice AP
    J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
    Zhou Q; Chen D; Pierstorff E; Luo K
    EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavopiridol inhibits P-TEFb and blocks HIV-1 replication.
    Chao SH; Fujinaga K; Marion JE; Taube R; Sausville EA; Senderowicz AM; Peterlin BM; Price DH
    J Biol Chem; 2000 Sep; 275(37):28345-8. PubMed ID: 10906320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.
    Zhou M; Deng L; Lacoste V; Park HU; Pumfery A; Kashanchi F; Brady JN; Kumar A
    J Virol; 2004 Dec; 78(24):13522-33. PubMed ID: 15564463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat.
    Brès V; Gomes N; Pickle L; Jones KA
    Genes Dev; 2005 May; 19(10):1211-26. PubMed ID: 15905409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of HEXIM1 at Tyr271 and Tyr274 Promotes Release of P-TEFb from the 7SK snRNP Complex and Enhances Proviral HIV Gene Expression.
    Mbonye UR; Wang B; Gokulrangan G; Chance MR; Karn J
    Proteomics; 2015 Jun; 15(12):2078-86. PubMed ID: 25900325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replication.
    Flores O; Lee G; Kessler J; Miller M; Schlief W; Tomassini J; Hazuda D
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7208-13. PubMed ID: 10377393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation.
    Brès V; Yoshida T; Pickle L; Jones KA
    Mol Cell; 2009 Oct; 36(1):75-87. PubMed ID: 19818711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of P-TEFb disrupts global transcription, oocyte maturation, and embryo development in the mouse.
    Oqani RK; Lin T; Lee JE; Kim SY; Sa SJ; Woo JS; Jin DI
    Genesis; 2016 Sep; 54(9):470-82. PubMed ID: 27488304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo.
    Chao SH; Price DH
    J Biol Chem; 2001 Aug; 276(34):31793-9. PubMed ID: 11431468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-TEFb as A Promising Therapeutic Target.
    Fujinaga K
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32075058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription.
    Barboric M; Yik JH; Czudnochowski N; Yang Z; Chen R; Contreras X; Geyer M; Matija Peterlin B; Zhou Q
    Nucleic Acids Res; 2007; 35(6):2003-12. PubMed ID: 17341462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR.
    Sedore SC; Byers SA; Biglione S; Price JP; Maury WJ; Price DH
    Nucleic Acids Res; 2007; 35(13):4347-58. PubMed ID: 17576689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.